Life sciences cloud software provider Veeva Systems (NYSE:VEEV) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 16% year on year to $836 million. Guidance for next ...

With broad industry success and the availability of Veeva AI, Vault CRM is the leader in agentic CRM for life sciencesPLEASANTON, Calif., March 3, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) ...

The deal with Walgreens is likely to enhance sales of Veeva Data Cloud products including Veeva OpenData, Link, and Compass products. This partnership benefits Veeva Systems by expanding its reach ...

A decade from now, you might be very glad you did so.

It's worth sticking with the stock through the hard times.

Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Mid Cap Growth Fund”. A copy of the letter can be downloaded here.

Veeva Systems is a leading global provider of cloud software solutions for life sciences companies such as drugmakers, biotech companies and medical device makers. The company is steadily growing ...

Veeva Systems (NYSE:VEEV) has approved a new $2b share repurchase plan. The company is prioritizing AI adoption across ...

Veeva Systems is executing well its migration plan from Salesforce to Veeva Vault CRM, positioning itself for double-digit revenue growth. Better than expected Q2 2023 results with revenue of $590.2 ...

Veeva Systems is performing well and demonstrating strong management execution, making it a buy. The company's R&D solutions and Veeva Vault CRM migration are key factors for future growth. Veeva's ...

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and ...